Table 2 Clinical characteristics of the study population and comparative effectiveness of FPT in LPN
LPN group 1(57) | LPN group 2 (9) | P | |
|---|---|---|---|
Gestational age (wks) | 35.1 ± 0.8 | 35.8 ± 0.4 | 0.02 |
Birthweight (g) | 2657 ± 481 | 2603 ± 256 | 0.74 |
Gender (male) | 26 (45.6) | 5 (55.5) | 0.58 |
AB0 mismatch | 8 (14.0) | 1 (11.1) | 0.81 |
Rh mismatch | 3 (5.3) | 1 (11.1) | 0.49 |
Cesarean section | 15 (26.3) | 0 | 0.09 |
Apgar score at 5’ | 9.2 ± 0.7 | 9.3 ± 0.5 | 0.59 |
SGA | 2 (3.5) | 1 (11.1) | 0.31 |
Age at FPT start (h) | 49 ± 17 | 55 ± 12 | 0.33 |
TSB at FPT start (mg/dl) | 12.6 ± 2.0 | 13.6 ± 1.2 | 0.17 |
TSB at FPT stop (mg/dl) | 8.9 ± 2.0 | 10.7 ± 1.5 | 0.01 |
FPT duration (h) | 50.5 ± 18.4 | 50.9 ± 23.2 | 0.95 |
TSB reduction at stop of FPT (%) | 28.9 ± 14.5 | 20.0 ± 16.0 | 0.10 |
TSB hourly reduction in PT (mg/dl/h) | 0.08 ± 0.06 | 0.07 ± 0.07 | 0.65 |
TSB maximum rebound (%) | 24.4 ± 20.2 | 28.0 ± 15.0 | 0.61 |
Check numbers after discharge | 1.9 ± 1.2 | 2.2 ± 1.6 | 0.51 |
Birthweight variation (%) | 3.7 ± 3.2 | 2.9 ± 1.9 | 0.47 |
Weight variation during phototherapy (%) | −0.2 ± 2.4 | −0.8 ± 1.1 | 0.46 |
TSB reduction after 24 h of FPT (%) | 15.0 ± 9.0 | 13.0 ± 11.0 | 0.55 |